Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07071324 · ClinicalTrials.gov registry record · NA
CF Wellness Program
A NA study of Insomnia and Fatigue, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 3
- Study locations
NCT07071324: Recruiting NA study of Insomnia and Fatigue, sponsored by Johns Hopkins University.
NCT07071324 is a NA study of Insomnia and Fatigue that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 80 participants, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (53% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07071324, a NA study of Insomnia and Fatigue, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study is a pilot randomized control trial (RCT; N=80) comparing the Cystic Fibrosis Wellness Program (CFWP) to usual care (UC) to evaluate (1) Intervention Adherence (completion of the CFWP Coaching Sessions) (2) Study Retention (completion of the Week 15 assessment) and (3) Data Quality (valid daytime and nighttime fitness tracker data). A secondary aim is to gather preliminary data to determine if the CFWP has a clinically significant signal over usual care to improve fatigue, sleep, and physical activity (PA) and reduce sedentary behavior.
Primary Outcome
The number of participants randomized to receive the CFWP who complete all 8 coaching sessions.
Conditions Studied
Interventions
- BEHAVIORAL CF Wellness Program
Study Locations (3)
Colorado
- National Jewish Health - Denver
Maryland
- Johns Hopkins University - Baltimore
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-02-03 |
| Est. Completion | 2028-06-30 |
| Phase | NA |
What NCT07071324 shows while recruiting
NCT07071324 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 170-participant average among 151 other Insomnia trials with a reported enrollment target (53% lower).
The record links to 4 conditions, with Insomnia appearing as the primary indexed condition, and to 1 intervention - of which CF Wellness Program is the first listed.
NCT07071324 reports a single indexed study location in Colorado, Maryland, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT07071324 about?
NCT07071324 is a clinical study titled "CF Wellness Program". This study is a pilot randomized control trial (RCT; N=80) comparing the Cystic Fibrosis Wellness Program (CFWP) to usual care (UC) to evaluate (1) Intervention Adherence (completion of the CFWP Coaching Sessions) (2) Study Retention (completion of the Week 15 assessment) and (3) Data Quality (valid...
What is the current status of trial NCT07071324?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2026-02-03. Estimated completion is 2028-06-30.
What conditions does trial NCT07071324 study?
This clinical trial studies the following conditions: Insomnia, Fatigue, Cystic Fibrosis (CF), Sleep Quality.
What interventions are being tested in trial NCT07071324?
The interventions under investigation include: CF Wellness Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT07071324?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07071324 being conducted?
This trial has 3 study locations across Colorado, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07071324's enrollment target sits among peer trials
80 74th of 151 higher than 73 of 151 other Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
mPATH for Low-income Older Adults
RECRUITING · NA
-
Accelerated Treatment for Co-occurring Insomnia, Nightmares, and PTSD
RECRUITING · NA
-
Adapted CBT-I for Adolescents With Insomnia : The DREAM-IT Study
RECRUITING · NA
-
Treatments in Women Veterans With Insomnia and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI